07 March 2025 : Clinical Research
Predicting Visual Recovery in Long-Standing Macular Holes: Surgical Strategies and Role of Optical Coherence Tomography Biomarkers
Agnieszka Nowosielska
ABCDEF 1*
DOI: 10.12659/MSM.946109
Med Sci Monit 2025; 31:e946109
Table 1 Patient demographic and baseline characteristics.
| Parameter | Patients (N=50) |
|---|---|
| Age, y | |
| Mean (SD) | 73 (7) |
| Median | 69 |
| Range | 65–85 |
| Women, (%) | 36 (72.0) |
| Preoperative BCVA in affected eye, logMAR | |
| Mean (SD) | 1.0 (0.4) |
| Range | 0.5–1.6 |
| Macular hole duration, months | |
| Mean (SD) | 19.1 (8.8) |
| Range | 12–43 |
| Macular hole diameter, μm | |
| Mean (SD) | 569.2 (164.6) |
| Range | 247–822 |
| Macular hole diameter, n (%) | |
| Small to medium (≤400 μm) | 12 (24.0) |
| Duration of macular hole, mean (SD), months | 12.8 (1.1) |
| Large to extra-large (>400 μm) | 38 (76.0) |
| Duration of macular hole, mean (SD), months | 21.0 (9.2) |
| BCVA – best-corrected visual acuity; logMAR – logarithm of the minimum angle of resolution. | |